Treatment Horizons

At the 16th European AIDS Conference in Milan, Italy, on October 25, 2017, Janssen Pharmaceutica, NV announced the results of its Phase 3 AMBER...

Hide and Seek Led by Dr. Daria Hazuda, researchers tackle HIV latency with HDAC inhibitors by Chael Needle With all the talk around viral suppression, it may...

LifeGuide Opening Doors A new survey uncovers barriers to treatment by Chael Needle There’s an old chestnut that goes something like this: People won’t make a change...

Close to the Edit A functional cure candidate modifies genes to create HIV-resistant cells by Chael Needle Gary Blick, MD, AAHIVS, Medical & Research Director of CIRCLE...

Nuclear Waste How to get overwhelmed by the data on new nukes, old nukes & lots of different classes of ART at AIDS 2014 by Mariel...

A bacterium with a live biotherapeutic grows into a microbicide candidate by Chael Needle LifeGuide The development of female-initiated HIV prevention methods—female condoms, antiretroviral treatment as prevention,...

When it comes to Effective HIV reform, don’t throw the baby out with the bathwater by Mariel Selbovitz, MPH, and Leslie G Selbovitz, MD LifeGuide Extensive progress in...

NAPWA helps to promote immune-based therapies by Chael Needle At the International AIDS Conference last June, the AIDS Institute and the National Association of People with AIDS...

A treatment for advanced HIV-associated Kaposi’s sarcoma is relaunched by Chael Needle Newly acquired by Galen from Gilead Sciences, DaunoXome (daunorubicin citrate liposome injection) is an...

Stronger Punch? Monoclonal antibodies provide new hope for easier dosing by Jeannie Wraight With multi-drug, once-a-day therapies now available for use, the push for additional easier to...